Valík D - Search Results

1

[New Indings in Methotrexate Pharmacology - Diagnostic Possibilities and Impact on Clinical Care].

Řiháček M, Pilatova K, Štěrba J, Pilný R, Valík D. Řiháček M, et al. Among authors: valik d. Klin Onkol. 2015;28(3):163-70. doi: 10.14735/amko2015163. Klin Onkol. 2015. PMID: 26062617 Review. Czech.

2

[Lactate Dehydrogenase - Old Tumour Marker in the Light of Current Knowledge and Preanalytic Conditions].

Greplová K, Selingerová I, Valík D, Pilatova K, Češková M, Zdražilová Dubská L. Greplová K, et al. Among authors: valik d. Klin Onkol. 2017 Spring;30(Supplementum1):156-158. Klin Onkol. 2017. PMID: 28471194 Czech.

3

[Can we Observe Ethnic Difference in Basic Blood Tests? Single-institution Data from Cancer Prevention Programme in the Czech Republic].

Řiháček M, Valík D, Vyzula R, Zdražilová Dubská L. Řiháček M, et al. Among authors: valik d. Klin Onkol. 2017 Spring;30(Supplementum1):170-173. Klin Onkol. 2017. PMID: 28471198 Czech.

4

[Profiles of low-molecular proteome spectrum obtained through SELDI-TOF mass spectrometry in the sera of patients with metastatic malignant melanoma: pilot study].

Lakomý R', Greplová K, Pilný R, Budinská E, Valík D, Poprach A, Nemecek R, Vyzula R. Lakomý R', et al. Among authors: valik d. Klin Onkol. 2009;22(5):228-32. Klin Onkol. 2009. PMID: 19886361 Czech.

5

B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia.

Rihacek M, Bienertova-Vasku J, Valik D, Sterba J, Pilatova K, Zdrazilova-Dubska L. Rihacek M, et al. Among authors: valik d. Biomed Res Int. 2015;2015:792187. doi: 10.1155/2015/792187. Epub 2015 Aug 3. Biomed Res Int. 2015. PMID: 26339644 Free PMC article. Review.

6

High-dose methotrexate and/or leucovorin rescue for the treatment of children with lymphoblastic malignancies: do we really know why, when and how?

Sterba J, Valík D, Bajciová V, Kadlecová V, Gregorová V, Mendelová D. Sterba J, et al. Among authors: valik d. Neoplasma. 2005;52(6):456-63. Neoplasma. 2005. PMID: 16284689 Review.

7

Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited.

Sterba J, Dusek L, Demlova R, Valik D. Sterba J, et al. Among authors: valik d. Clin Chem. 2006 Apr;52(4):692-700. doi: 10.1373/clinchem.2005.061150. Epub 2006 Feb 2. Clin Chem. 2006. PMID: 16455868

8

Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.

Fědorová L, Pilátová K, Selingerová I, Bencsiková B, Budinská E, Zwinsová B, Brychtová V, Langrová M, Šefr R, Valík D, Zdražilová Dubská L. Fědorová L, et al. Among authors: valik d. Klin Onkol. 2018 Winter;31(Suppl 2):88-92. Klin Onkol. 2018. PMID: 31023030 English.

9

Homocysteine: exploring its potential as a pharmacodynamic biomarker of antifolate chemotherapy.

Valik D, Radina M, Sterba J, Vojtesek B. Valik D, et al. Pharmacogenomics. 2004 Dec;5(8):1151-62. doi: 10.1517/14622416.5.8.1151. Pharmacogenomics. 2004. PMID: 15584881 Review.

10

Severe encephalopathy induced by the first but not the second course of high-dose methotrexate mirrored by plasma homocysteine elevations and preceded by extreme differences in pretreatment plasma folate.

Valik D, Sterba J, Bajciova V, Demlova R. Valik D, et al. Oncology. 2005;69(3):269-72. doi: 10.1159/000088334. Epub 2005 Sep 15. Oncology. 2005. PMID: 16166815

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters